Kefir Research

• Abdelali, H., Cassand, P., Soussotte, V., et al, 1995. Effect of dairy products on initiation of precursor lesions of colon cancer in rats. Nutr Cancer 24:121-32.

• Abdelali, H., Cassand, P., Soussotte, V., et al, 1995. Antimutagenicity of component of dairy products. Mutat Res 331:133-41.

• Aiba, Y., Suzuki, N., Kabir, A.M., et al, 1998. Lactic acid-mediated suppression of Hp by the oral administration of Lactobacillius salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 93:2097-101.

• Alander, M., Korpela, R., Saxelin, M., et al, 1997. Recovery of Lactobacilius rhamnosus GG from human colonic biopsies. Lett Appl Microbiol 24:361-4.

• Alm, L., 1983. Survival rate of Salmonella and Shigella in fermented milk products with and without added human gastric juice: an in vitro study. Prog Food Nutr Sci 7:19-28.

• Alm L., 1982. Effect of fermentation on lactose, glucose, and galactose content in milk and suitability of fermented milk products for lactose intolerant individuals. J Dairy Sci 65:346-52.

• Arihara, K., Toba, T., Adachi, S., 1990. Immunofluorescence microscopic studies on distribution of L. kefiranofaciens and L. kefir in kefir grains. Int J Food Microbiol 11:127-34.

• Arunachalam, K.D., 1999. Role of Bifidobacteria in nutrition, medicine and technology. Nutr Res 19:1559-97.

• Baricault, L., Denariaz, G., Houri, J.J., et al, 1995. Use of HT-29, a culture human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16:245-52.

• Bazhenov, L.G., Bondarenko, V.M., Lykova, E.A., et al, 1997. The antagonistic action of lactobacilli on Hp. Zh Mikrobiol Epidemiol Immunobiol 3:89-91.

• Besednova, N.N., Epshtein, L.M., Gazha, A.K., et al, 1997 Therapeutic-prophylactic milk products with a new immunocorrector of natural origin. Vopr Pitan 3:31-4.

• Beshkova, D.M., Simova, E.D., et al, 2002. Pure cultures for making kefir. Food Microbiology 19(5):537-544.

• Bouhnik, Y., Flourie, B., Andrieux, C., et al, 1996. Effects of B. sp. fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans. Eur J Clin Nutr 50:269-73.

• Bouhnik, Y., Flourie, B., et al, 1997. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy human. J Nutr 127:444.

• Cassand, P., Abdelali, H., Bouley, C., et al, 1994. Inhibitory effect of dairy products on the mutagenicities of chemicals and dietary mutagens. J Dairy Res 61:545-52.

• De Vrese, M., Keller, B., Barth, C.A., 1992. Enhancement of intestinal hydrolysis of lactose by microbial beta-galactosidase (EC 3.2.1.23) of kefir. Br J Nutr 67:67-75.

• Donnet-Hughes, A., Rochat, F., Serrant, P., et al, 1999. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J Dairy Sci 82:863-9.

• Fukushima, Y., Kawata, Y., Mizumachi, K., et al, 1999. Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse. Int J Food Microbiol 46:193-7.

• Gallaher, D.D., Stallings, W.H., Blessin, L.L., et al, 1996. Probiotics, cecal microflora, and aberrant crypts in the rat colon. J Nutr 126:1362-71.

• Garrote, G.L., Abraham, A.G., De Antoni, G.L., 2001. Chemical and microbiological characterisation of kefir grains. J Dairy Res 68(4):639-652.

• Garrote, G.L., Abraham, A.G., De Antoni, G.L., 2000. Inhibitory power of kefir: the role of organic acids. J Food Protection 63(3):364-369.

• Gismondo, M.R., Lo Bue, A.M., Chisari, G., et al, 1990 Competitive activity of a bacterial preparation on colonization and pathogenicity of C. pylori. A clinical study. Clin Ter 134:41-6.

Guzel-Seydim, Z., et al, 2005. Turkish kefir and kefir granins: microbial enumeration and electron microscopic observation. Int J Dairy Sci 58(1):25.

• Jiang, T., Savaiano, D.A., 1997. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacilius acidophilus supplementation. J Nutr 127:1489-95.

• Kabir, A.M., Aiba, Y., Takagi, A., et al. Prevention of Hp infection by lactobacilli in a gnotobiotic murine model. Gut 1997;41:49-55.

• Kubo, M., Odani, T., Nakamura, S., et al, 1992. Pharmacological study on kefir-a fermented milk product in Caucasus on antitumor activity. Yakugaku Zasshi 112:489-95.

• Levy, J. 1998. Immunonutrition: the pediatric esperience. Nutrition 14:641-7.

• Lykova, E.A., Bondarenko, V.M., et al, 1996. The probiotic correction of microecological and immune disorders in gastroduodenal pathology in children. Zh Mikrobiol Epidemiol Immunobiol 2:88-91.

• Majamaa, H., Isolauri, E., 1997. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 99:179-85.

• Midolo, P.D., Lambert, J.R., Hull, R., et al, 1995. In vitro inhibition of Hp NCTC 11637 by organic acids and lactic acid bacteria. J Appl Bacteriol 79:475-9.

• Murofushi, M., Mizuguchi, J., Aibara, K., et al, 1986 Immunopotentiative effect of polysaccharide from kefir grain, KGF-C, administered orally in mice. Immunopharmacology 121:29-35.

• Murofushi, M., Shiomi, M., Aibara, K., 1983. Effect of orally administered polysaccharide from kefir grain on delayed-type hypersensitivity and tumor growth in mice. Jpn J Med Sci Biol 36:49-53.

• Osada, K., Nagira, K., Teruya, K., et al, 1993. Enhancement of interferon-beta production with sphingomyelin from fermented milk. Biotherapy 7:115-23.

• Partaskevopoulou, A., Athanasiadis, I., et al, 2003. Functional properties of single cell protein produced by kefir microflora. Food Res Intl 36(5):431-438.

• Pessi, T., et al, 1998. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutics uses of probiotics. J Nutr 128:2313-8.

• Pool-Zobel, B.L., Munzner, R., Holzapfel, W.H., 1993. Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay. Nutr Cancer 23:261-70.

• Rani, B., Khetarpaul, N., 1998. Probiotic fermented food mixture: possible applications in clinical anti-diarrhoea usage. Nutr Health 12:97-105.

• Robertfroid, M.B., Bornet, F., Bouley, C., et al, 1995. Colonic microflora: Nutrition and health. Summary and conclusions of and International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain. Nutr Rev 53:127-30.

• Rosi, J., 1978. Kefir micro-organisms: yeasts. Scienza e Tecnica Lattiero-Casearia 29 (2) pp. 59-67.

• Ryan, M.P., Rea, M.C., Hill, C., et al, 1996. An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol 62:612-9.

• Salminen, S., Bouley, C., et al, 1998. Functional food science and gastrointestinal physiology and function. Br J Nutr 80(suppl. 1):S147-71.

• Saltzman, J.R., Russell, R.M., 1998. The aging gut. Nutritional issues. Gastroenterol Clin North Am 27:309-24.

• Santos, A., Mauro, M.S., Sanchez, A., et al, 2003. The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir. Syst App Microbio 26(3):434-437.

• Schaafsma, G., Meuling, W.J., Van Dokkum, W., et al, 1998. Effect of a milk product, fermented by L. acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. J Clin Nutr 52:436-40.

• Roberfroid, M.B., 1998, Prebiotics and synbiotics: concepts and nutritional properties. Br J Nutr 80:S197-202.

• Rodrigues, K.L., Carvlaho, J.C.T., Schneedorf, J.M., 2005. Anti-inflammatory properties of kefir and its polysaccharide extract. Inflammopharmacology 13(5-6):485-492.

• Schiffrin, E.J., Brassart, D., Servin, A.L., et al, 1997. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66:515S-20S.

• Shiomi, M., Aibara, K., Murofushi, M., et al, 1983. Effect of orally administered polysaccharide from kefir grain on delayed-type hypersensitivity and tumor growth in mice. Jpn J Med Sci Biol 36:49- 53.

• Shiomi, M., Sasaki, K., Murofushi, M., et al, 1982. Antitumor activity in mice of orally administered polysaccharide from kefir grain. Jpn J Med Sci Biol 35:75-80.

• Silva, A.M., Bambirra, E.A., Oliveira, A.L., et al, 1999. Protective effect of bifidus milk on the experimental infection with Salmonella enteritilis subsp. Typhimurium in conventional and gnotobiotic mice. J Appl Microbiol 86:331-6.

• Solis-Pereyra, B., Aattouri, N., Lemonnier, D., 1997. Role of food in the stimulation of cytokine production. Am J Clin Nutr 66:521S-5S.

• Spanhaak, S., Havenaar, R., Schaafsma, G., 1998. The effect of consumption of milk fermented by Lactobacilius casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52: 899-907.

• Sukhov, S.V., Kalamkarova, L.I., Ilchenko, L.A., et al, 1986. Microfloral changes in the small and large intestines of chronic enteritis patients an diet therapy including sour milk products. Vopr Pitan 4:14-7.

• Teruya, K., Yamashita, M., Tominaga, R., et al, 2002. Fermented milk, Kefram-Kefir enhances glucose uptake into insulin-responsive muscle cells. Cytotechnology 40(1-3):107-116.

• Tratnik, et al, 2006. The quality of plain and supplemented kefir from goat's and cow's milk. Int J Dairy Tech 59(1):40-46.

• Vass, A., Szakaly, S., Schmidt, P., 1984. Experimental study of the nutitional biological characters of fermented milks. Acta Med Hung 41:157-61.

Witthuhn, R.C., Schoeman, T., Britz, T.J., 2004. Isolation and characterization of the microbial population of different South African kefir grains. Int J Dairy Tech 57(1):33-37.

• Yokoi, H., Watanabe, T., Fujii, Y., et al, 1991. Some taxonomical characteristics of encapsulated L. sp KPB-167B isolated from kefir grains and characterization of its extracellular polysaccharide. Int J Food Microbiol 13:257-64.

Zubillaga, M., Weill, R., Postaire, E., et al, 2001. Effect of probiotics and functional foods and their use in different diseases. Nutrition Res 21(3):569-579.